logo
Select company
Select metric
$ 11.08MNet Cash Flow - Financing
VS
Market
32
Sector
42
Industry
33
History
23
$ 4.49Close
$ 1.71 - $ 12.7 52-Week Range
Ticker Information

Ticker

CATX

Company Name

PERSPECTIVE THERAPEUTICS INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NYSEMKT

PERSPECTIVE THERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CATX - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 11.08M
3/31/2025$ 133.03M
12/31/2024$ 289.38M
9/30/2024$ 289.39M
6/30/2024$ 288.76M
3/31/2024$ 167.19M
12/31/2023$ 785K
9/30/2023$ 433K
6/30/2023$ 460K
3/31/2023$ -52K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PERSPECTIVE THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 994K.
  • Over the past 5 years, PERSPECTIVE THERAPEUTICS INC's average CF - Financing has been $ 70.84M.
  • The median CF - Financing for PERSPECTIVE THERAPEUTICS INC during this period was $ 6.04M
  • PERSPECTIVE THERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 289.39M.
  • The lowest CF - Financing recorded by PERSPECTIVE THERAPEUTICS INC in the same timeframe $ -52K

PERSPECTIVE THERAPEUTICS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
RNAC : CARTESIAN THERAPEUTICS INC $ 117.31MINBX : INHIBRX BIOSCIENCES INC $ 99.84MNWBO : NORTHWEST BIOTHERAPEUTICS INC $ 51.74MHUMA : HUMACYTE INC $ 100.76MSI : SHOULDER INNOVATIONS INC -PAVM : PAVMED INC $ 6.21MCODX : CO-DIAGNOSTICS INC $ 887.66KMGRM : MONOGRAM TECHNOLOGIES INC $ 18.08MMREO : MEREO BIOPHARMA GROUP PLC $ -346KCV : CAPSOVISION INC -

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

CATX - Net Cash Flow - Financing, Last 5 years

$ -52K

Minimum

Mar 31, 2023

$ 289.39M

Maximum

Sep 30, 2024

$ 70.84M

Average

$ 6.04M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.74M with a standard deviation of $ 119.11M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -367.1M
max$ 366M
average$ -6.74M
median$ 314K
std$ 119.11M